<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="ppul24810-tbl-0002" xml:lang="en" content-type="Table" orientation="portrait" position="float">
 <label>Table 2</label>
 <caption>
  <p>SARS acronym: more cons than pros</p>
 </caption>
 <table frame="hsides" rules="groups">
  <col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/>
  <tbody valign="top">
   <tr style="border-bottom:solid 1px #000000">
    <td style="border-bottom:solid 1px #000000" valign="top" rowspan="1" colspan="1">
     <bold>Pros</bold>
    </td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <p>
      <list list-type="bullet">
       <list-item>
        <p>The clinical definition can be applied to any similar epidemics for surveillance without knowing the culprit pathogen.</p>
       </list-item>
      </list>
     </p>
    </td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <p>
      <list list-type="bullet">
       <list-item>
        <p>Sensitive.</p>
       </list-item>
      </list>
     </p>
    </td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <p>
      <list list-type="bullet">
       <list-item>
        <p>The SARS concept of surveillance is easy to apply in epidemics.</p>
       </list-item>
      </list>
     </p>
    </td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <p>
      <list list-type="bullet">
       <list-item>
        <p>The acronym is used even in afebrile, asymptomatic carriers or patients with mild and extrapulmonary symptoms in some laboratory‐confirmed SARS patients.</p>
       </list-item>
      </list>
     </p>
    </td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <bold>Cons</bold>
    </td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <p>
      <list list-type="bullet">
       <list-item>
        <p>Stigmatizing many patients because the definition is too nonspecific or too sensitive.</p>
       </list-item>
      </list>
     </p>
    </td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <p>
      <list list-type="bullet">
       <list-item>
        <p>May not be used for a non‐coronavirus (eg, influenza or measles) or another novel coronavirus (eg, MERS) even if the symptoms are severe, acute and respiratory.</p>
       </list-item>
      </list>
     </p>
    </td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <p>
      <list list-type="bullet">
       <list-item>
        <p>May miss nonfebrile patients or patients with extrapulmonary symptoms.</p>
       </list-item>
      </list>
     </p>
    </td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <p>
      <list list-type="bullet">
       <list-item>
        <p>Contact or travel history is only good in early phase of an epidemic.</p>
       </list-item>
      </list>
     </p>
    </td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <p>
      <list list-type="bullet">
       <list-item>
        <p>New acronym has to be coined (eg, MERS for Middle East respiratory syndrome, WARS for Wuhan acute respiratory syndrome, CARS for Canton and MARS for Macau or Moscow acute respiratory syndrome, and COVID‐19 for coronavirus disease in 2019).</p>
       </list-item>
      </list>
     </p>
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="ppul24810-tbl2-note-0001">
   <p>Abbreviation: SARS, severe acute respiratory syndrome.</p>
  </fn>
 </table-wrap-foot>
 <permissions>
  <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
  <license>
   <license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p>
  </license>
 </permissions>
</table-wrap>
